Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Review: hepatitis delta

S J Hadziyannis1

  • 1Academic Department of Medicine, Hippokration General Hospital, Athens, Greece.

Journal of Gastroenterology and Hepatology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Hepatitis delta virus (HDV) is a unique subviral agent affecting over 10 million people globally. Advances in molecular biology offer new insights into HDV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients.

Alimentary pharmacology & therapeutics·2016
Same author

Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

Alimentary pharmacology & therapeutics·2015
Same author

Letter: safe and effective cessation of long-term nucleos(t)ide analogue therapy in noncirrhotic patients with HBeAg-negative chronic hepatitis B.

Alimentary pharmacology & therapeutics·2014
Same author

Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection?

Alimentary pharmacology & therapeutics·2014
Same author

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

Journal of viral hepatitis·2013
Same author

Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C.

Alimentary pharmacology & therapeutics·2013
Same journal

Patient-Level Predictors of Procedural Success in Colon Capsule Endoscopy: A Systematic Review and Meta-Analysis.

Journal of gastroenterology and hepatology·2026
Same journal

Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality.

Journal of gastroenterology and hepatology·2026
Same journal

Toward the Era of Precision Immunotherapy: The Clinical Landscape and Future Directions of mRNA Vaccines for the Treatment of Hepatocellular Carcinoma.

Journal of gastroenterology and hepatology·2026
Same journal

From Chronic Atrophic Gastritis to Low-Grade Intraepithelial Neoplasia: A Proteomic Study on the Sequential Progression of Gastric Precancerous Lesions.

Journal of gastroenterology and hepatology·2026
Same journal

Resource-Stratified Carbon-Adjusted Quality Indicators for Green Endoscopy.

Journal of gastroenterology and hepatology·2026
Same journal

Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort.

Journal of gastroenterology and hepatology·2026
See all related articles

Area of Science:

  • Virology
  • Hepatology
  • Molecular Biology

Background:

  • Hepatitis delta virus (HDV) is an unusual subviral agent, unique in infecting animal species.
  • HDV requires the hepatitis B virus (HBV) as a helper virus and affects over 10 million individuals worldwide.
  • Hepatitis D remains a significant global health concern due to chronic liver disease, including hepatocellular carcinoma.

Purpose of the Study:

  • To review current knowledge on the molecular biology of HDV.
  • To discuss the clinical relevance of recent molecular findings for HDV infection.
  • To explore implications for pathogenesis, diagnosis, disease course, and potential therapies.

Main Methods:

  • Review of molecular studies on HDV life cycle and protein functions.

Related Experiment Videos

  • Analysis of sensitive assays like polymerase chain reaction (PCR) and sequencing for HDV-RNA.
  • Examination of epidemiological data on changing HDV prevalence and endemicity.

    • Main Results:

    • Molecular studies have significantly advanced understanding of HDV's life cycle and protein functions.
    • PCR and sequencing have clarified HDV transmission patterns and identified unusual clinical forms.
    • Hepatitis D prevalence is shifting, with decreasing rates in some areas and new endemic foci.

    Conclusions:

    • New molecular insights into HDV have clinical relevance for pathogenesis, diagnosis, and management.
    • Liver transplantation shows high success rates for delta cirrhosis, offering insights into HDV biology.
    • Prevention and treatment strategies for hepatitis D are still developing, despite advances in understanding.